SCHEMBL30784459

SCHEMBL30784459

Cc1cc(Br)c2nc(Cl)n(C(C)C)c(=O)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 2/20 0.40
▸ F2RL3 Q96RI0 1/20 0.34
▸ PRNP P04156 1/20 0.34
▸ PPARG P37231 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ NCOA2 Q15596 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ NR2E3 Q9Y5X4 1/20 0.34
▸ NCOR2 Q9Y618 1/20 0.34
▸ DDR1 Q08345 3/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ NR1I2 O75469 1/20 0.31
▸ ADRA2A P08913 1/20 0.31
▸ ADORA3 P0DMS8 1/20 0.31
▸ TBXA2R P21731 1/20 0.31
▸ PTGS2 P35354 1/20 0.31
▸ OPRD1 P41143 1/20 0.31
▸ PDE4D Q08499 1/20 0.31
▸ MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30336004 0.81 EGFR (0.43) EGFRF2RL3PRNPPPARGHTT
SCHEMBL25360881 0.81 EGFR (0.43) EGFRF2RL3PRNPPPARGHTT
SCHEMBL15228751 0.78 ALDH1A1 (0.39) HTTNPSR1L3MBTL1MEN1KMT2A
SCHEMBL30784404 0.77 EGFR (0.40) EGFRF2RL3PRNPPPARGHTT
SCHEMBL25360747 0.77 DDR1 (0.42) EGFRF2RL3PRNPPPARGHTT
SCHEMBL30721027 0.77 DDR1 (0.42) EGFRF2RL3PRNPPPARGHTT
SCHEMBL30721048 0.75 EGFR (0.39) EGFRF2RL3PRNPPPARGHTT
SCHEMBL26957673 0.75 EGFR (0.39) EGFRF2RL3PRNPPPARGHTT
SCHEMBL30784510 0.75 PIK3CB (0.39) EGFR
SCHEMBL30784349 0.73 DDR1 (0.38) EGFRF2RL3PRNPPPARGHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026424-A1 QUINAZOLINONE DERIVATIVES AS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback